A nurse is preparing to administer a medication to a client.

Complete the following sentence by using the lists of options.

The nurse should first address the client's

dropdown

followed by the client's

dropdown

.

Anaphylaxis is a severe type I hypersensitivityreaction characterized by systemic mast cell degranulation and bronchoconstriction. While epinephrine is the first-line treatment for its vasopressorand bronchodilatory effects, refractory respiratory distress requires secondary interventions to stabilize the airway. Targeted beta-2 agonists are used to provide localized relief of bronchospasm.

Rationale:

A.Selegiline is a monoamine oxidase inhibitor (MAOI) used primarily in the management of Parkinson's disease. It has no role in the acute treatment of anaphylaxis or respiratory distress. Administering an MAOI in an emergency setting could actually lead to dangerous drug interactions with the epinephrine already given, potentially triggering a hypertensive crisis or cardiac arrhythmia.

B.Abatacept is a selective costimulation modulator used for the treatment of rheumatoid arthritis by inhibiting T-cell activation. It is a maintenance medication for chronic autoimmune conditions and does not provide the rapid bronchodilation required for an acute allergic emergency. Its onset of action is far too slow to address the immediate threat of airway occlusion following a bee sting.

C.Sucralfate is a gastroprotective agent that forms a complex over ulcer sites in the stomach. It is administered orally and has no systemic effect on the respiratory or cardiovascular systems. Using sucralfate in a client with severe dyspnea is inappropriate and dangerous, as the patient is at high risk for aspiration and requires immediate parenteral or inhaled interventions.

D.Albuterol is a rapid-acting beta-2 adrenergic agonist that provides direct bronchodilation to relieve the wheezing and airway constriction associated with anaphylaxis. When a client has a suboptimal response to epinephrine, inhaled albuterol helps to further relax the smooth muscles of the bronchioles. This is a critical secondary intervention to improve ventilation and reduce the work of breathing.

Active tuberculosis is an infectious disease caused by Mycobacterium tuberculosisrequiring combination chemotherapyto eradicate persistent bacilli and prevent multidrug resistance. Standard regimens utilize bactericidalagents like isoniazid and rifampin to achieve sterilization of infected tissues and prevent clinical relapse.

Rationale:

A.Monthly monitoring of kidney function is not a standard requirement for primary tuberculosis medications like isoniazid or rifampin, which are primarily hepatotoxic. While some aminoglycosides used for resistant cases affect renal status, the main concern for most patients is liver enzyme elevation. The nurse should focus on monitoring hepatic function and signs of jaundice instead of routine renal labs.

B.Taking two or more medications is essential because Mycobacterium tuberculosisis highly prone to developing resistance if treated with monotherapy. Using a combination, such as the RIPE (rifampin, isoniazid, pyrazinamide, ethambutol) regimen, ensures that different bacterial populations and metabolic states are targeted simultaneously. This strategy is the cornerstone of preventing the emergence of multidrug-resistant tuberculosis strains during the long course of treatment.

C.Treatment for active tuberculosis typically lasts 6 to 9 months, rather than 3 years, for drug-susceptible cases. Extending therapy to 3 years is not standard practice and could lead to significant toxicity and non-compliance issues. The nurse must provide an accurate timeline to the client to ensure they understand the necessity of completing the entire several-month course.

D.Tuberculin skin tests are used for screening and diagnosis but are not useful for monitoring treatment progress in a patient already diagnosed with active disease. Once a skin test is positive, it will likely remain positive regardless of treatment success. Progress is instead monitored through sputum cultures, chest radiographs, and clinical improvement in symptoms like cough and fever.